HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Govindarajan Rajagopalan Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

1/2013Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome.
5/2007Autoimmunity in HLA-DQ8 transgenic mice expressing granulocyte/macrophage-colony stimulating factor in the beta cells of islets of Langerhans.
9/2003Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans.
2/2003Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules.
11/2002Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Govindarajan Rajagopalan Research Topics

Disease

13Septic Shock (Toxic Shock Syndrome)
01/2020 - 11/2004
7Infections
01/2024 - 10/2006
6Inflammation (Inflammations)
10/2018 - 02/2006
5Autoimmune Diseases (Autoimmune Disease)
10/2018 - 04/2006
5Pneumonia (Pneumonitis)
10/2017 - 06/2012
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2013 - 11/2002
5Shock
06/2012 - 07/2002
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2015 - 11/2011
3Genetic Predisposition to Disease (Genetic Predisposition)
11/2015 - 01/2008
2Lung Injury
01/2023 - 01/2022
2Bacteremia
08/2019 - 08/2015
2Neoplasms (Cancer)
01/2018 - 06/2010
2Foodborne Diseases
06/2010 - 12/2008
1Bacterial Infections (Bacterial Infection)
01/2024
1Pseudomonas Infections
04/2023
1Hyperoxia
01/2022
1Cytokine Release Syndrome
01/2020
1COVID-19
01/2020
1Immunoglobulin G4-Related Disease
10/2018
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
05/2017
1Wound Infection (Wound Infections)
12/2015
1Wounds and Injuries (Trauma)
12/2015
1Glomerulonephritis
11/2015
1Lupus Nephritis
11/2015
1Melanoma (Melanoma, Malignant)
10/2015
1Neoplasm Metastasis (Metastasis)
10/2015
1Endocarditis
06/2014
1Hyperglycemia
01/2013
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
06/2012
1Sialadenitis
05/2007
1Colitis
04/2006

Drug/Important Bio-Agent (IBA)

19SuperantigensIBA
01/2020 - 11/2004
9HLA-DR3 Antigen (HLA DR3 Antigen)IBA
10/2017 - 11/2002
8staphylococcal enterotoxin BIBA
01/2021 - 11/2004
6CytokinesIBA
06/2012 - 11/2004
5HLA-DQ8 antigenIBA
01/2014 - 07/2002
4ExotoxinsIBA
12/2015 - 02/2007
4HLA Antigens (Human Leukocyte Antigens)IBA
10/2012 - 11/2002
3AntibodiesIBA
01/2020 - 01/2011
2Interleukin-17 (Interleukin 17)IBA
01/2023 - 01/2020
2InterferonsIBA
01/2020 - 02/2011
2Adrenal Cortex Hormones (Corticosteroids)IBA
10/2018 - 05/2017
2Linezolid (Zyvox)FDA Link
10/2017 - 10/2012
2Peptides (Polypeptides)IBA
10/2015 - 11/2004
2Enterotoxins (Enterotoxin)IBA
06/2014 - 06/2012
1Investigational DrugsIBA
01/2024
1Anti-Bacterial Agents (Antibiotics)IBA
04/2023
1PorphyrinsIBA
04/2023
1ZincIBA
04/2023
1Oxygen (Dioxygen)IBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Janus Kinase InhibitorsIBA
01/2020
1Chimeric Antigen ReceptorsIBA
01/2020
1Rituximab (Mabthera)FDA Link
10/2018
1AutoantibodiesIBA
10/2018
1AutoantigensIBA
10/2018
1SteroidsIBA
10/2018
1TNF-Related Apoptosis-Inducing LigandIBA
01/2018
1Immunoglobulin Fc FragmentsIBA
10/2017
1Immunoglobulin G (IgG)IBA
10/2017
1Bacterial Proteins (Bacterial Protein)IBA
10/2017
1Formoterol Fumarate (Oxis)FDA Link
05/2017
1Budesonide (Pulmicort)FDA LinkGeneric
05/2017
12,6-dinitrotoluene (DNT)IBA
01/2017
1HLA-DR2 Antigen (HLA DR2 Antigen)IBA
11/2015
1AntigensIBA
10/2015
1ImmunosorbentsIBA
06/2014
1EnzymesIBA
06/2014
1Staphylococcal enterotoxin FIBA
06/2014
1lipoteichoic acidIBA
01/2014
1Lipoproteins (Lipoprotein)IBA
01/2014
1Peptidoglycan (Murein)IBA
01/2014
1Pathogen-Associated Molecular Pattern MoleculesIBA
01/2014
1Caseins (Casein)FDA Link
01/2013
1Glutens (Glutelin)IBA
01/2013
1VancomycinFDA LinkGeneric
10/2012
1ChemokinesIBA
06/2012
1Immunosuppressive Agents (Immunosuppressants)IBA
06/2012
1Tacrolimus (Prograf)FDA LinkGeneric
06/2012
1HLA-D AntigensIBA
11/2011
1Interferon-gamma (Interferon, gamma)IBA
02/2011
1Bortezomib (Velcade)FDA Link
06/2010
1Biological Warfare AgentsIBA
06/2010
1LipopolysaccharidesIBA
06/2010
1NF-kappa B (NF-kB)IBA
06/2010
1Proteasome InhibitorsIBA
06/2010
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2008
1HLA-DR Antigens (HLA-DR)IBA
01/2008
1Histocompatibility Antigens Class IIIBA
05/2007
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2007
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2007
1Freund's AdjuvantIBA
04/2006

Therapy/Procedure

5Therapeutics
01/2024 - 06/2012
1Phage Therapy
01/2024
1Artificial Respiration (Mechanical Ventilation)
05/2017
1Immunotherapy
10/2015
1Catheters
08/2015
1Gluten-Free Diet
01/2013
1Drug Therapy (Chemotherapy)
06/2010
1Intravaginal Administration
02/2007